Skip to content

Corruption Ledger

The Public Ledger of Corruption

  • About
  • Corruption
    • banks
    • corporate
    • environment
    • government
    • health
    • Leaks
    • misinformation
    • privacy and surveillance
    • Protest and Unrest
  • Sanctions
    • Sanctions News
    • Global Sanctions Feed
    • European Sanctions Feed
    • Canadian Sanctions Feed
    • US Sanctions Feed
  • Regions
    • Asias
    • Europe
    • Middle East
    • Oceania
    • US & Canada
    • World
  • Enforcement
  • Economy
  • International Conflict
  • Tech
  • Cryptocurrency
  • Free Speech
  • Toggle search form
  • Wells Fargo fined for sanctions breach _enforcement
  • Google Co-Founder, Other Billionaires Are Issued Subpoenas in Lawsuit Over JPMorgan’s Ties to Jeffrey Epstein; Sergey Brin, Thomas Pritzker, Mortimer Zuckerman and Michael Ovitz are asked for information in U.S. Virgin Islands’ civil suit against bank All Regions
  • Chinese businessman Guo Wengui seeks bail in $1 billion fraud case All Regions
  • IMF approves $15.6 billion Ukraine loan, part of $115 billion in global support All Regions
  • Russian preventive strike ‘petition’ possible after Ukrainian nuke plea -ITAR-TASS All Regions
  • Dominion’s Fox News defamation case headed to trial All Regions
  • Pussy Riot Member Accused of ‘Insulting Religious Sensibilities’, adds her to wanted list All Regions
  • Finland Clears Last Obstacle to NATO Entry All Regions

Former CEO Laura PERRYMAN of STIMWAVE LLC Indicted Selling Fake Medical Component that Was Implanted into Patients

Posted on March 13, 2023March 22, 2023 By 4am Research No Comments on Former CEO Laura PERRYMAN of STIMWAVE LLC Indicted Selling Fake Medical Component that Was Implanted into Patients

Department of Justice
U.S. Attorney’s Office
Southern District of New York

FOR IMMEDIATE RELEASE
Thursday, March 9, 2023

Medical Device Company Admitted Wrongdoing and Entered into Non-Prosecution Agreement Requiring $10 Million Monetary Penalty and Ongoing Compliance Measures

Damian Williams, the United States Attorney for the Southern District of New York, Michael J. Driscoll, the Assistant Director in Charge of the New York Field Office of the Federal Bureau of Investigation (“FBI”), and Fernando P. McMillan, the Special Agent in Charge of the New York Field Office of the U.S. Food and Drug Administration – Office of Criminal Investigations (“FDA-OCI”), announced today the filing of a two-count Indictment (the “Indictment”) charging Laura PERRYMAN, the former Chief Executive Officer (“CEO”) of STIMWAVE LLC, a Florida-based medical device company, in connection with a scheme to create and sell a non-functioning dummy medical device for implantation into patients suffering from chronic pain, resulting in millions of dollars in losses to federal healthcare programs.  PERRYMAN was arrested this morning in Delray Beach, Florida, and will be presented later today in the United States District Court for the Southern District of Florida.  

In addition, Mr. Williams announced the unsealing of a non-prosecution agreement (the “Agreement”) with STIMWAVE LLC (“STIMWAVE”), which filed for bankruptcy on June 15, 2022.  The Agreement was entered into on October 29, 2022, and was sealed by the United States Bankruptcy Court for the District of Delaware, pending the Government’s ongoing investigation.  Under the terms of the Agreement, STIMWAVE has accepted responsibility for its conduct by, among other things: (i) making admissions and stipulating to the accuracy of an extensive Statement of Facts; (ii) paying a $10,000,000 monetary penalty; and (iii) maintaining an adequate compliance program, to include employing a Chief Compliance Officer and holding regular compliance committee meetings.  STIMWAVE is also required to cooperate fully with the Government.  STIMWAVE’s obligations under the Agreement will continue for a period of three years from the date of execution of the Agreement.   

The U.S. Attorney’s Office also unsealed a civil fraud lawsuit filed against STIMWAVE under the False Claims Act (“FCA”), and the parties’ settlement of that suit (the “FCA Settlement”).  The settlement has been submitted to United States District Judge George B. Daniels for approval.  In connection with the FCA Settlement, STIMWAVE admitted and accepted responsibility for conduct alleged in the Government’s civil complaint and agreed to pay $8,600,000 to the United States.  This payment will be credited towards the $10,000,000 monetary penalty discussed above.  The civil complaint also brings claims against PERRYMAN under the FCA, which are pending.

U.S. Attorney Damian Williams said: “As alleged, at the direction of its founder and CEO Laura Perryman, Stimwave created a dummy medical device component — made entirely of plastic — designed to be implanted in patients for the sole purpose of causing doctors to unwittingly bill Medicare and private insurance companies more than $16,000 for each implantation of the piece of plastic.  The defendant and Stimwave did this so that they could charge medical providers many thousands of dollars for purchasing their medical device.  Our Office will continue to do everything in its power to bring to justice anyone responsible for perpetuating health care fraud, which in this case led to patients being used as nothing more than tools for financial enrichment.”

FBI Assistant Director Michael J. Driscoll said: “Ms. Perryman, as the Chief Executive Officer of Stimwave, allegedly led a scheme to sell medical devices that contained a non-functioning component that doctors unwittingly implanted into patients suffering from chronic pain.  As a result of her illegal actions, not only did patients undergo unnecessary implanting procedures, but Medicare was defrauded of millions of dollars.  Today’s action demonstrates the FBI’s continuing commitment to protect Medicare and other government programs from financial fraud and abuse.”

FDA-OCI Special Agent in Charge Fernando P. McMillan said: “Individuals and companies that manufacture and distribute medical devices with non-functional components put the health of patients at significant risk.  We will continue to pursue and bring to justice those who jeopardize the health of their patients and of the public.”

According to the documents unsealed today in Manhattan federal court and the United States Bankruptcy Court for the District of Delaware:[1]

STIMWAVE was a medical device company that manufactured and distributed implantable neurostimulation devices designed to treat intractable, chronic pain.  Founded in 2010 by PERRYMAN and others, STIMWAVE was headquartered in Pompano Beach, Florida.

STIMWAVE was founded on the premise that its products would provide non-opioid alternatives to chronic pain management.  As the founder and CEO of STIMWAVE, PERRYMAN oversaw the design of the StimQ PNS System (the “Device”), a neurostimulator medical device that treated chronic pain by producing electrical currents to target peripheral nerves outside the spinal cord.  From at least in or about 2017 up to and including her termination in or about 2019, PERRYMAN, as STIMWAVE’s CEO, engaged in a multi-year scheme (the “Scheme”) to design, create, manufacture, and market an inert, non-functioning component of the Device — called the “White Stylet” — that served no medical purpose but was included with the Device through in or about 2020 in order to make the product financially viable for doctors to purchase. 

When STIMWAVE originally brought the Device to market in or about 2017, it contained three primary components: (i) an implantable electrode array (the “Lead”) that stimulated the nerve; (ii) an externally worn battery that sat outside the body and wirelessly provided power to the Lead through the patient’s skin (the “Battery”); and (iii) a separate implantable receiver measuring approximately 23 centimeters in length with a distinctive pink handle — called the “Pink Stylet.”  The Pink Stylet contained copper and, unlike the White Stylet, functioned as a receiver to transmit energy from the Battery to the Lead.

STIMWAVE sold the Device to doctors and medical providers for over approximately $16,000.  Medical insurance providers, including Medicare, would reimburse medical practitioners for implanting the Device into patients through two separate reimbursement codes, one for implantation of the Lead and a second for implantation of the Pink Stylet.  The billing code for implanting the Lead provided for reimbursement at a rate of between approximately $4,000 and $6,000, while the billing code for implanting a receiver, like the Pink Stylet, provided for reimbursement at a rate of between approximately $16,000 and $18,000.

Soon after the Device was released, physicians informed STIMWAVE that they were having trouble implanting the Pink Stylet in certain patients because the Pink Stylet was too long.  STIMWAVE and PERRYMAN knew that the Pink Stylet could not be cut or trimmed to shorten it without interfering with the functionality of the Pink Stylet as a receiver, and without a receiver component for doctors to implant and seek reimbursement for, doctors would incur a substantial financial loss with every purchase of the Device, thereby making it more difficult for STIMWAVE to sell the Device to doctors and medical providers at the approximately $16,000 price.

However, STIMWAVE — at the direction of PERRYMAN — did not lower the price of the Device so that its cost to doctors and medical providers could be covered by reimbursement for the implantation of only the Lead, nor did PERRYMAN recommend that doctors not implant the Device or its receiver component in cases where the Pink Stylet could not fit comfortably.  Instead, PERRYMAN directed that STIMWAVE create the White Stylet — a dummy component made entirely of plastic that served no medical purpose but which STIMWAVE misrepresented to doctors as a customizable receiver alternative to the Pink Stylet.  The White Stylet could be cut to size by the doctor for use in smaller anatomical spaces and was created solely so that doctors and medical providers would continue to purchase the Device for use in those scenarios and continue to bill for the implantation of a receiver component.  To perpetuate the lie that the White Stylet was functional, PERRYMAN oversaw training that suggested to doctors that the White Stylet was a “receiver,” when, in fact, it was made entirely of plastic, contained no copper, and therefore had no conductivity.  In addition, PERRYMAN directed other STIMWAVE employees to vouch for the efficacy of the White Stylet, when she knew that the White Stylet was actually non-functional.

As a result of these misrepresentations regarding the functionality of the White Stylet, PERRYMAN caused doctors and medical providers to unwittingly implant the non-functional White Stylet into patients and submit fraudulent reimbursement claims for implantation of the White Stylet to Medicare, resulting in millions of dollars in losses to the federal government.

On June 15, 2022, STIMWAVE filed for bankruptcy in Delaware under Chapter 11 of the Bankruptcy Code, through which it sold substantially all of its assets to a third-party through an auction.

*                *                *

PERRYMAN, 54, of Delray Beach, Florida, has been charged with one count of conspiracy to commit wire fraud and health care fraud, which carries a maximum potential sentence of 20 years in prison, and one count of health care fraud, which carries a maximum potential sentence of 10 years in prison. 

The maximum potential sentences are prescribed by Congress and are provided here for informational purposes only, as any sentencing of the defendant will be determined by the judge. 

Mr. Williams praised the investigative work of the FBI and thanked the FDA for its assistance.

The criminal case is being handled by the Complex Frauds and Cybercrime Unit of the Office’s Criminal Division.  Assistant U.S. Attorneys Louis A. Pellegrino, Jacob M. Bergman, and Mónica P. Folch are in charge of the prosecution.  The civil case against STIMWAVE and PERRYMAN is being handled by the Civil Frauds Unit of the Office’s Civil Division.  Assistant U.S. Attorneys Jacob M. Bergman and Mónica P. Folch are in charge of the civil case.

The charges contained in the Indictment are merely accusations, and the defendant is presumed innocent unless and until proven guilty.

________________________________________
[1] As the introductory phrase signifies, the entirety of the text of the Indictment constitutes only allegations, and every fact described herein should be treated as an allegation.

Contact: 
Nicholas Biase (212) 637-2600

Press Release Number: 
23-094

fda.gov

banks, enforcement archive, z-Exclude Tags:FDA

Post navigation

Previous Post: With Biden visit to Canada, U.S. will seek commitment on leading a Haiti security force
Next Post: Kremlin critic Kara-Murza goes on trial for treason

See also

  • Kingwood Orlando Reunion Resort, Kingwood Crystal River Resort Florida Resorts to Pay $325,000: False Claims Act Allegations Relating to False Certifications on Paycheck Protection Program Loan Forgiveness Application enforcement archive
  • US credit card debt at record high as Fed raises rates again All Regions
  • US says retaliatory airstrikes in Syria killed eight Iran-backed fighters Aerospace
  • EU’s 6th package of anti-Russian sanctions: oil embargo, banking bans, media bans _enforcement
  • Finance companies and their directors fined for misconduct _enforcement
  • DOJ Announces New Compensation Incentives and Clawbacks Pilot Program Compliance

You must log in to post a comment.

  • Wells Fargo fined for sanctions breach
  • Google Co-Founder, Other Billionaires Are Issued Subpoenas in Lawsuit Over JPMorgan’s Ties to Jeffrey Epstein; Sergey Brin, Thomas Pritzker, Mortimer Zuckerman and Michael Ovitz are asked for information in U.S. Virgin Islands’ civil suit against bank
  • Chinese businessman Guo Wengui seeks bail in $1 billion fraud case
  • IMF approves $15.6 billion Ukraine loan, part of $115 billion in global support
  • Dominion’s Fox News defamation case headed to trial
  • Pussy Riot Member Accused of ‘Insulting Religious Sensibilities’, adds her to wanted list
  • Russian preventive strike ‘petition’ possible after Ukrainian nuke plea -ITAR-TASS
  • Finland Clears Last Obstacle to NATO Entry
  • Macron announces water saving plan; says protests will not stop reforms
  • Kremlin comments on WSJ correspondent arrest
  • Minnesota derailment spills ethanol, prompts evacuations
  • Deutsche Bank Stock Tumbles On Contagion Fears
  • Wall St falls as bank contagion fears flare up
  • US due diligence firm Mintz Group says staff detained in China after office raid
  • Credit Suisse, UBS facing US Russia-sanctions probe, subpoenas also sent to employees major US banks
  • (US) Appeals court sides with Justice Department in Trump lawyer fight
  • Russia boosts defenses near Japan; accuses U.S. of expanding Asia-Pacific presence
  • US credit card debt at record high as Fed raises rates again
  • Russian tech giants appeal Nasdaq delisting
  • China Denounces Submarine Deal
  • China insists it is impartial on Russia-Ukraine, questions US ‘pouring weapons into the conflict’
  • German ambassador confirms that Putin would be arrested if he entered Germany
  • Danish Navy present near Nord Stream 2 – media
  • Railroad reluctant to say who OK’d chemical burn after Ohio derailment
  • Scientists insist on continuing search for toxics in East Palestine
  • Top aide of Canadian PM Trudeau will testify in parliament on Chinese election meddling
  • Zuckerberg, Meta sued for failing to address sex trafficking, child exploitation
  • Norfolk Southern: Independent group finds toxic chemicals that Ohio EPA didn’t – Ohio train derailment (East Palestine)
  • JP Morgan, Deutsche Bank to face lawsuit over Epstein ties
  • Putin announces readiness to switch to the Chinese Yuan currency in foreign trade
  • Putin and Xi sign two documents in Moscow
  • Russia says jet scrambled as US B-52 bombers fly over Baltic Sea
  • Paris police, protesters clash for third night over Macron’s pension reform
  • Global / ChipMixer software ‘taken down’ by multi-national law enforcement coalition
  • Russian officials scoff at ICC’s indictment of Putin
  • SVB parent company files for bankruptcy
  • Violent protests in France over Macron’s retirement age push
  • International court issues war crimes warrant for Putin
  • US / Chinese tycoon and Bannon ally Guo Wengui charged with $1bn fraud
  • Samsung to invest $230 billion to build mega chip cluster
  • Pentagon calls Moscow over drone incident
  • Credit Suisse slump renews fears of global banking crisis
  • Silicon Valley Bank execs, parent company sued after collapse
  • Credit Suisse Shares Plunge as Bank Storm Spreads to Europe
  • Dow tumbles nearly 500 points as Credit Suisse stokes fears of bank failure contagion
  • Russian jet, US drone crash over Black Sea, US military says
  • Dark hours for Credit Suisse Bank
  • Account full of holes at Credit Suisse
  • Russia blasts Canada over ‘regime change’
  • US / Sterling Bancorp, Inc. to Plead Guilty to $69M Securities Fraud
  • US drones have no business near Russia – ambassador
  • Inflation in Argentina surges past 100 percent in historic spike
  • Paris visitors alarmed at trash strike
  • China says AUKUS on ‘dangerous path’ with nuclear subs deal
  • Taiwan unveils portable attack drone as China tensions rise
  • Putin rejects theory about Ukrainian role in pipeline blasts
  • Syrian president Assad arrives in Moscow, set to meet Putin
  • Marin’s F-18 proposal fizzles, as a new Finnish NATO tack emerges
  • Ohio sues Norfolk Southern over toxic train derailment
  • US / ‘Forever chemicals’ in drinking water
  • Nord Stream blasts staged by a state-level actor – Putin
  • No Harvey Weinstein retrial on rape, sex assault charges
  • US / Silicon Valley Bank execs, parent company sued after collapse
  • As U.S. steps back from Middle East, China steps in
  • Western sanctions shielding Russian financial system from global crisis – Kremlin
  • Moody’s puts US banks on notice
  • Robert Kiyosaki predicts next big bank to fold
  • UK $6 billion defense boost targets atomic submarines, weapons top-up
  • BBC gets £20 million boost from UK govt
  • Document reveals why Canada arms Saudi Arabia – media
  • Taiwan braces for ‘total blockade’ – media
  • Biden administration lets Ukrainians who fled war stay in US
  • Ratings Deceit: S&P sued for deceitful CDO ratings
Rumble Video

Corruption Ledger Follow

The Public ▇▇▇ Ledger of ▇▇▇ Corruption. https://t.co/wkobrEotQR

5amResearch
Corruption Ledger @5amresearch ·
10 Feb

News Coverage of the September 2022 #NordStream Pipeline Attack https://corruptionledger.com/news-coverage-of-the-september-2022-nord-stream-pipeline-attack/ via @5amResearch

Reply on Twitter 1623868066818928641 Retweet on Twitter 1623868066818928641 Like on Twitter 1623868066818928641
Corruption Ledger @5amresearch ·
10 Feb

Mia Jankowicz of Business Insider calls Pulitzer prize-winning journalist Seymore Harsh a "discredited journalist." #NordStream

Reply on Twitter 1623857264086974464 Retweet on Twitter 1623857264086974464 Like on Twitter 1623857264086974464 1
Corruption Ledger @5amresearch ·
9 Feb

#Kraken to Discontinue Unregistered Offer and Sale of Crypto Asset Staking-As-A-Service Program and Pay $30 Million to Settle SEC Charges
https://www.sec.gov/news/press-release/2023-25

Reply on Twitter 1623815305452560384 Retweet on Twitter 1623815305452560384 Like on Twitter 1623815305452560384
Corruption Ledger @5amresearch ·
9 Feb

SpaceX: Ukraine breaching agreement, weaponizing Starlink https://en.mdn.tv/71FW

Reply on Twitter 1623685510496505860 Retweet on Twitter 1623685510496505860 Like on Twitter 1623685510496505860
Load More

–

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2022 Corruption Ledger. This web site contains no ads.